High Pathologic Complete Response Rates of BRCA1-Positive Breast Cancers after Neoadjuvant Chemotherapy with Cisplatin

被引：0
|
作者：
Hof, Holger
机构：
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2010年 / 186卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：463 / 465
页数：3
相关论文
共 50 条
  • [31] MRI predicts pathologic complete response in HER2-positive breast cancer after neoadjuvant chemotherapy
    van Ramshorst, Mette S.
    Loo, Claudette E.
    Groen, Emilie J.
    Winter-Warnars, Gonneke H.
    Wesseling, Jelle
    van Duijnhoven, Frederieke
    Peeters, Marie-Jeanne T. Vrancken
    Sonke, Gabe S.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 164 (01) : 99 - 106
  • [32] High Tumor Grade Predicts Pathologic Complete Response in Breast Cancer Patients after Neoadjuvant Chemotherapy
    Fayanju, O. M.
    Yan, Y.
    Jeffe, D. B.
    Margenthaler, J. A.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S46 - S46
  • [33] Correlation between breast and axillary pathologic complete response after neoadjuvant chemotherapy in breast cancer
    Yildirim, Emine
    Bektas, Sibel
    Yetis, Firat
    Yildiz, Eren Ozan
    Ozdemir, Muhammed
    Komut, Neslihan
    Calik, Mustafa
    Er, Ahmet Muzaffer
    ANNALI ITALIANI DI CHIRURGIA, 2023, 94 (04) : 336 - 345
  • [34] MRI and Prediction of Pathologic Complete Response in the Breast and Axilla after Neoadjuvant Chemotherapy for Breast Cancer
    Weber, Joseph J.
    Jochelson, Maxine S.
    Eaton, Anne
    Zabor, Emily C.
    Barrio, Andrea V.
    Gemignani, Mary L.
    Pilewskie, Melissa
    Van Zee, Kimberly J.
    Morrow, Monica
    El-Tamer, Mahmoud
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2017, 225 (06) : 740 - 746
  • [35] Platinum-based neoadjuvant chemotherapy in BRCA1-positive breast cancer: a retrospective cohort analysis and literature review
    Saether, Nikolai Havn
    Skuja, Elina
    Irmejs, Arvids
    Maksimenko, Jelena
    Miklasevics, Edvins
    Purkalne, Gunta
    Gardovskis, Janis
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2018, 16
  • [36] The Impact of Facility Volume on Rates of Pathologic Complete Response to Neoadjuvant Chemotherapy Used in Breast Cancer
    Ajmani, Gaurav S.
    James, Ted A.
    Kantor, Olga
    Wang, Chi-Hsiung
    Yao, Katharine A.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (11) : 3157 - 3166
  • [37] The Impact of Facility Volume on Rates of Pathologic Complete Response to Neoadjuvant Chemotherapy Used in Breast Cancer
    Gaurav S. Ajmani
    Ted A. James
    Olga Kantor
    Chi-Hsiung Wang
    Katharine A. Yao
    Annals of Surgical Oncology, 2017, 24 : 3157 - 3166
  • [38] Pathologic complete response rates following neoadjuvant chemotherapy in the treatment of locally advanced breast cancer
    Prabhudesai, S. R.
    Malini, A. V.
    Raghavendra, R. M.
    Ashwini, N. R.
    Geetha, V. P.
    Patil, S.
    Diwakar, R. B.
    Gopinath, K. S.
    Srinath, B. S.
    Raizada, N.
    Somorat, B.
    Naik, R.
    Giri, S. P.
    Ajaikumar, B. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [39] Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy
    M Tanioka
    C Shimizu
    K Yonemori
    K Yoshimura
    K Tamura
    T Kouno
    M Ando
    N Katsumata
    H Tsuda
    T Kinoshita
    Y Fujiwara
    British Journal of Cancer, 2010, 103 : 297 - 302
  • [40] Predictors of Pathologic Complete Response in Axillary Nodes After Neoadjuvant Chemotherapy for Breast Cancer
    Ahn, Soojin
    Romeiser, Jamie
    O'Hea, Brian
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : 24 - 25
12345